In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a doxycycline hyclate 20 mg twice daily Drug Master File in Korea (doxycycline hyclate 20 mg twice daily KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of doxycycline hyclate 20 mg twice daily. The MFDS reviews the doxycycline hyclate 20 mg twice daily KDMF as part of the drug registration process and uses the information provided in the doxycycline hyclate 20 mg twice daily KDMF to evaluate the safety and efficacy of the drug.
After submitting a doxycycline hyclate 20 mg twice daily KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their doxycycline hyclate 20 mg twice daily API can apply through the Korea Drug Master File (KDMF).
click here to find a list of doxycycline hyclate 20 mg twice daily suppliers with KDMF on PharmaCompass.